FCA
AZN icon

FinTrust Capital Advisors’s AstraZeneca AZN Stock Holding History

FinTrust Capital Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$873K Buy
5,600
+252
+5% +$40.7K 0.15% 127
2024
Q2 		$834K Buy
5,348
+1,036
+24% +$156K 0.15% 126
2024
Q1 		$584K Buy
4,312
+30
+0.7% +$3.97K 0.11% 157
2023
Q4 		$577K Sell
4,282
-333
-7% -$43.3K 0.11% 160
2023
Q3 		$625K Sell
4,615
-1,722
-27% -$235K 0.14% 145
2023
Q2 		$892K Hold
6,337
– – 0.21% 115
2023
Q1 		$873K Hold
6,337
– – 0.21% 114
2022
Q4 		$859K Buy
6,337
+1,677
+36% +$210K 0.21% 116
2022
Q3 		$511K Buy
4,660
+1,986
+74% +$252K 0.13% 158
2022
Q2 		$353K Sell
2,674
-6
-0.2% -$787 0.09% 195
2022
Q1 		$355K Buy
2,680
+2,500
+1,389% +$300K 0.08% 205
2021
Q4 		$21K Hold
180
– – 0.01% 732
2021
Q3 		$22K Buy
180
+63
+54% +$7.33K 0.01% 718
2021
Q2 		$14K Buy
117
+19
+19% +$2.08K ﹤0.01% 836
2021
Q1 		$10K Buy
98
+58
+145% +$5.83K ﹤0.01% 888
2020
Q4 		$4K Buy
40
+21
+111% +$2.22K ﹤0.01% 966
2020
Q3 		$2 Sell
19
-48
-72% -$5.34K ﹤0.01% 1052
2020
Q2 		$7K Sell
67
-43
-39% -$4.44K ﹤0.01% 775
2020
Q1 		$10K Sell
110
-10
-8% -$941 ﹤0.01% 747
2019
Q4 		$12K Sell
120
-16
-12% -$1.51K ﹤0.01% 712
2019
Q3 		$12K Sell
136
-71
-34% -$6.16K ﹤0.01% 724
2019
Q2 		$17K Sell
207
-160
-44% -$12.5K 0.01% 637
2019
Q1 		$30K Buy
367
+4
+1% +$315 0.01% 497
2018
Q4 		$28K Buy
+363
New +$28.3K 0.01% 505

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FinTrust Capital Advisors's AZN Position: Q3 2024 in Review

FinTrust Capital Advisors increased its AstraZeneca (AZN) stake by 4.7% in Q3 2024, buying an estimated $40.7K and bringing the position to 5,600 shares worth $873K. The position accounts for 0.15% of the portfolio, ranked #127.

FinTrust Capital Advisors first reported a position in AZN in Q4 2018 and has held it in 24 quarters since. The position peaked at $892K in Q2 2023. 1,229 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • FinTrust Capital Advisors held 5,600 shares of AstraZeneca worth $873K as of Q3 2024.
  • FinTrust Capital Advisors bought 252 AstraZeneca shares in Q3 2024, an estimated $40.7K.
  • AstraZeneca made up 0.15% of FinTrust Capital Advisors's portfolio in Q3 2024, its #127 holding.
  • FinTrust Capital Advisors first reported a position in AstraZeneca in Q4 2018 and has held it in 24 quarters since.
  • FinTrust Capital Advisors's AstraZeneca position peaked at $892K in Q2 2023.
  • 1,229 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.